Alector (ALEC) Other financing activities (2018 - 2026)
Alector's (ALEC) quarterly Other financing activities came in at $23000.0 in Q2 2026, down 81.15% year-over-year from $122000.0 in Q2 2025, and down 8.0% quarter-over-quarter from $25000.0 in Q1 2026.
Analysis
Alector (ALEC) Other financing activities (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Other financing activities for 9 consecutive years, with $23000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other financing activities fell 81.15% year-over-year to $23000.0 in Q2 2026; TTM through Jun 2026 was $143000.0, a 72.55% decrease from a year earlier, with the FY2025 full-year figure at $217000.0, down 79.19% from the prior year.
- Other financing activities was $23000.0 for Q2 2026 at Alector, down from $25000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $2.5 million in Q1 2022 and troughed at $23000.0 in Q2 2026.
- A 5-year average of $486500.0 and a median of $257000.0 in 2023 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities sank 99.41% in 2022 and soared 752.17% in 2023, its largest moves.
- Over 5 years, Other financing activities stood at $46000.0 in 2022, then soared by 752.17% to $392000.0 in 2023, then advanced by 1.79% to $399000.0 in 2024, then tumbled by 76.19% to $95000.0 in 2025, then tumbled by 75.79% to $23000.0 in 2026.
- The last three Other financing activities figures came in at $23000.0 (Q2 2026), $25000.0 (Q1 2026), and $95000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | 95,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Dec 31, 2024 | 399,000.00 |
| Jun 30, 2024 | 644,000.00 |
| Dec 31, 2023 | 392,000.00 |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 46,000.00 |
| Sep 30, 2022 | 489,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 2.48 Mn |
| Dec 31, 2021 | 7.84 Mn |
| Sep 30, 2021 | 14.82 Mn |
| Jun 30, 2021 | 1.99 Mn |
| Mar 31, 2021 | 3.87 Mn |
| Dec 31, 2020 | 632,000.00 |
| Sep 30, 2020 | 286,000.00 |
| Jun 30, 2020 | 2.20 Mn |
| Mar 31, 2020 | 3.22 Mn |